Retevmo is a prescription medicine used to treat certain types of non-small cell lung cancer (NSCLC), medullary thyroid cancer (MTC), and other thyroid cancers that have spread to other parts of the body. If you have question, please e-mail Allevaire Indian Team or call Allevaire India on +91-9818274099 (Mr. Kamal Kaushal) for further details.
RETEVMO is a prescription medication used to treat metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC) and advanced or metastatic RET-mutant medullary thyroid cancer (MTC) in adult and pediatric patients 12 years of age and older who require systemic therapy. It is available as an oral capsule and is only available as a brand-name drug, not as a generic.
RETEVMO is a prescription medication used to treat metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC) and advanced or metastatic RET-mutant medullary thyroid cancer (MTC) in adult and pediatric patients 12 years of age and older who require systemic therapy. It is available as an oral capsule and is only available as a brand-name drug, not as a generic.
Retevmo is indicated for the treatment of patients with metastatic rearranged during transfection (RET) fusion-positive non-small cell lung cancer (NSCLC). It is also indicated for the treatment of adult and pediatric patients 12 years of age and older with advanced or metastatic RET-mutant medullary thyroid cancer (MTC) who require systemic therapy.
Medicine Name: RETEVMO
Generic Name: selpercatinib
Approval Date: May 8, 2020
Company Name: Genentech, Inc.
Retevmo (Selpercatinib) is available.
Get In Touch
ALS helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Retevmo (Selpercatinib) on prescription and Import License in Patient’s Name only.
For foreign countries patients, Retevmo (Selpercatinib) can be made available in Send your inquiry to find Retevmo (Selpercatinib) in China, Cambodia, Indonesia the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
For Retevmo (Selpercatinib) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details